| Literature DB >> 15887953 |
Wayne E Childers1, Magid A Abou-Gharbia, Michael G Kelly, Terrance H Andree, Boyd L Harrison, Douglas M Ho, Geoffrey Hornby, Donna M Huryn, Lisa Potestio, Sharon J Rosenzweig-Lipson, Jean Schmid, Deborah L Smith, Stacey J Sukoff, Gan Zhang, Lee E Schechter.
Abstract
A series of benzodioxanylpiperazine derivatives possessing a 4-aryl amide substituent was prepared and evaluated for 5-HT(1A) affinity and functional antagonist activity in vitro and in vivo. All of the compounds in this series possessed high affinity for the human 5-HT(1A) receptor and many displayed potent antagonist activity in vitro and varying degrees of intrinsic activity in vivo. Compound 11c (Lecozotan) was selected for further development and is currently in clinical trials.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15887953 DOI： 10.1021/jm049493z
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446